Policy & Advocacy

The MAPS Policy & Advocacy Department advocates for healing and justice. We work to eliminate barriers to psychedelic research, education, and care. We envision legal paradigms for psychedelic use …

Fact Sheets – August 2018

MAPS has recently created the following documents to provide information about various aspects of our work. Frequently Asked Questions: MDMA-Assisted Therapy for PTSD Fact Sheet: Phase 3 Trials of MDMA-Assisted …

Brochures

Learn more about our work. General MAPS Information (2017) Clinical Research (2019) Phase 3 Clinical Trials of MDMA-Assisted Therapy for Posttraumatic Stress Disorder (2017)

Psycomp Academic, a Tool for Psychedelic Researchers

MAPS’ ally PsyComp Academic is a free access resource for education pathways into research with psychedelic compounds. Psycomp identifies postgraduate and postdoctoral positions relevant to psychedelic …

Psychedelic Review Archives 1963-1971

Psychedelic Review,Vol. I, No. 1, June 1963 (complete pdf) Editorial Statement of Purpose “Can This Drug Enlarge Man’s Mind?”, Gerald Heard The Subjective After-Effects of Psychedelic …